Ozvan Bocher

Ozvan Bocher


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2020 in Human Genetics
Verified
Journal Article
Closed access
PDF file
OBOzvan Bocher
Ozvan Bocher
Emmanuelle GENINEmmanuelle GENIN
Emmanuelle GENIN

16 September 2022 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
OBOzvan Bocher
Ozvan Bocher
TLThomas E. Ludwig
Thomas E. Ludwig
MOMarie-Sophie Oglobinsky
Marie-Sophie Oglobinsky
GMGaëlle Marenne
Gaëlle Marenne
JDJean-François Deleuze
Jean-François Deleuze
Emmanuelle GENINEmmanuelle GENIN
Emmanuelle GENIN
Rare variant association tests (RVAT) have been developed to study the contribution of rare variants widely accessible through high-throughput sequencing technologies. RVAT require to aggregate rare variants in testing units and to filter variants to retain only the most likely causal ones. In the exome, genes are natural testing units and variants are usually filtered based on their functional consequences. However, when dealing with whole-genome sequence (WGS) data, both steps are challenging. No natural biological unit is available for aggregating rare variants. Sliding windows procedures have been proposed to circumvent this difficulty, however they are blind to biological information and result in a large number of tests. We propose a new strategy to perform RVAT on WGS data: “RAVA-FIRST” (RAre Variant Association using Functionally-InfoRmed STeps) comprising three steps. (1) New testing units are defined genome-wide based on functionally-adjusted Combined Annotation Dependent Depletion (CADD) scores of variants observed in the gnomAD populations, which are referred to as “CADD regions”. (2) A region-dependent filtering of rare variants is applied in each CADD region. (3) A functionally-informed burden test is performed with sub-scores computed for each genomic category within each CADD region. Both on simulations and real data, RAVA-FIRST was found to outperform other WGS-based RVAT. Applied to a WGS dataset of venous thromboembolism patients, we identified an intergenic region on chromosome 18 enriched for rare variants in early-onset patients. This region that was missed by standard sliding windows procedures is included in a TAD region that contains a strong candidate gene. RAVA-FIRST enables new investigations of rare non-coding variants in complex diseases, facilitated by its implementation in the R package Ravages.

13 May 2019 in Genetic Epidemiology
Verified
Journal Article
Closed access
PDF file
OBOzvan Bocher
Ozvan Bocher
GMGaëlle Marenne
Gaëlle Marenne
APAude Saint Pierre
Aude Saint Pierre
TLThomas E. Ludwig
Thomas E. Ludwig
SGStéphanie Guey
Stéphanie Guey
Emmanuelle GENINEmmanuelle GENIN
Emmanuelle GENIN

1 April 2021 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
LGLenaick Gourhant
Lenaick Gourhant
OBOzvan Bocher
Ozvan Bocher
LMLuc De Saint Martin
Luc De Saint Martin
TLThomas E. Ludwig
Thomas E. Ludwig
ABAnne Boland
Anne Boland
EPElisabeth Pasquier
Elisabeth Pasquier

Verified
Journal Article
Open access
PDF file
MCMégane Collobert
Mégane Collobert
OBOzvan Bocher
Ozvan Bocher
ANAnaïs Le Nabec
Anaïs Le Nabec
Emmanuelle GENINEmmanuelle GENIN
Emmanuelle GENIN
Claude FérecClaude Férec
Claude Férec
SMStéphanie Moisan
Stéphanie Moisan
About 8% of the human genome is covered with candidate cis-regulatory elements (cCREs). Disruptions of CREs, described as “cis-ruptions” have been identified as being involved in various genetic diseases. Thanks to the development of chromatin conformation study techniques, several long-range cystic fibrosis transmembrane conductance regulator (CFTR) regulatory elements were identified, but the regulatory mechanisms of the CFTR gene have yet to be fully elucidated. The aim of this work is to improve our knowledge of the CFTR gene regulation, and to identity factors that could impact the CFTR gene expression, and potentially account for the variability of the clinical presentation of cystic fibrosis as well as CFTR-related disorders. Here, we apply the robust GWAS3D score to determine which of the CFTR introns could be involved in gene regulation. This approach highlights four particular CFTR introns of interest. Using reporter gene constructs in intestinal cells, we show that two new introns display strong cooperative effects in intestinal cells. Chromatin immunoprecipitation analyses further demonstrate fixation of transcription factors network. These results provide new insights into our understanding of the CFTR gene regulation and allow us to suggest a 3D CFTR locus structure in intestinal cells. A better understand of regulation mechanisms of the CFTR gene could elucidate cases of patients where the phenotype is not yet explained by the genotype. This would thus help in better diagnosis and therefore better management. These cis-acting regions may be a therapeutic challenge that could lead to the development of specific molecules capable of modulating gene expression in the future.

14 April 2022 in Genetic Epidemiology
Verified
Journal Article
Closed access
GMGaëlle Marenne
Gaëlle Marenne
TLThomas E. Ludwig
Thomas E. Ludwig
OBOzvan Bocher
Ozvan Bocher
AHAnthony Herzig
Anthony Herzig
CAChaker Aloui
Chaker Aloui
EGEmmanuelle Génin
Emmanuelle Génin